Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPARROW trial of standard versus pre-emptive antibiotics after Whipple procedure
NL-OMON59546Phase 4Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metronidazole in surgical site infection (SSI) (2 arms), sponsored by Leiden University Medical Center. Primary endpoint: Clinically relevant organ/space infection. Started Mar 2023; status: recruiting.
02
Drugs
metronidazole
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NL-OMON59546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON59546.